172 related articles for article (PubMed ID: 35577856)
1. Label-free discrimination of tumorigenesis stages using in vitro prostate cancer bone metastasis model by Raman imaging.
Kar S; Jaswandkar SV; Katti KS; Kang JW; So PTC; Paulmurugan R; Liepmann D; Venkatesan R; Katti DR
Sci Rep; 2022 May; 12(1):8050. PubMed ID: 35577856
[TBL] [Abstract][Full Text] [Related]
2. In vitro design of mesenchymal to epithelial transition of prostate cancer metastasis using 3D nanoclay bone-mimetic scaffolds.
Molla MS; Katti DR; Katti KS
J Tissue Eng Regen Med; 2018 Mar; 12(3):727-737. PubMed ID: 28603879
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis.
Sieh S; Taubenberger AV; Lehman ML; Clements JA; Nelson CC; Hutmacher DW
Bone; 2014 Jun; 63():121-31. PubMed ID: 24530694
[TBL] [Abstract][Full Text] [Related]
5. Mechanobiological evaluation of prostate cancer metastasis to bone using an in vitro prostate cancer testbed.
Molla MS; Katti DR; Katti KS
J Biomech; 2021 Jan; 114():110142. PubMed ID: 33290947
[TBL] [Abstract][Full Text] [Related]
6. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Secreted Protein, Acidic and Rich in Cysteine in Prostate Carcinogenesis: Development of a 3D Nanostructured Bone-Like Model.
Ribeiro N; Costa-Pinheiro P; Henrique R; Gomez-Lazaro M; Pereira MP; Mansur AAP; Mansur HS; Jerónimo C; Sousa SR; Monteiro FJ
J Biomed Nanotechnol; 2016 Aug; 12(8):1667-78. PubMed ID: 29342345
[TBL] [Abstract][Full Text] [Related]
8. Behavior of prostate cancer cells in a nanohydroxyapatite/collagen bone scaffold.
Cruz-Neves S; Ribeiro N; Graça I; Jerónimo C; Sousa SR; Monteiro FJ
J Biomed Mater Res A; 2017 Jul; 105(7):2035-2046. PubMed ID: 28371333
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer metastases alter bone mineral and matrix composition independent of effects on bone architecture in mice--a quantitative study using microCT and Raman spectroscopy.
Bi X; Sterling JA; Merkel AR; Perrien DS; Nyman JS; Mahadevan-Jansen A
Bone; 2013 Oct; 56(2):454-60. PubMed ID: 23867219
[TBL] [Abstract][Full Text] [Related]
10. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
11. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
[TBL] [Abstract][Full Text] [Related]
12. Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.
Sung SY; Hsieh CL; Law A; Zhau HE; Pathak S; Multani AS; Lim S; Coleman IM; Wu LC; Figg WD; Dahut WL; Nelson P; Lee JK; Amin MB; Lyles R; Johnstone PA; Marshall FF; Chung LW
Cancer Res; 2008 Dec; 68(23):9996-10003. PubMed ID: 19047182
[TBL] [Abstract][Full Text] [Related]
13. Bone metabolism and new targets for intervention.
Akduman B; Crawford ED
Curr Urol Rep; 2007 May; 8(3):233-8. PubMed ID: 17459273
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
15. Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer.
Windus LC; Glover TT; Avery VM
Mol Cancer; 2013 Sep; 12(1):112. PubMed ID: 24073816
[TBL] [Abstract][Full Text] [Related]
16. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
17. Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo-osteogenic balance in bone marrow.
Wang C; Wang J; Chen K; Pang H; Li X; Zhu J; Ma Y; Qiu T; Li W; Xie J; Zhang J
Cancer Sci; 2020 Oct; 111(10):3600-3612. PubMed ID: 32770813
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
19. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT.
Peng X; Guo W; Liu T; Wang X; Tu X; Xiong D; Chen S; Lai Y; Du H; Chen G; Liu G; Tang Y; Huang S; Zou X
PLoS One; 2011; 6(5):e20341. PubMed ID: 21647377
[TBL] [Abstract][Full Text] [Related]
20. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
